Filed: 11/14/2023ACC: 0001104659-23-118127
📋 What this filing means
VENROCK ADVISER, LLC filed this quarterly 13F‑HR report disclosing 37 equity positions with a total reported market value of $949.95M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
37
Positions
$949.95M
Total AUM (reported)
117.25M
Total Shares
Allocation by class
COM$848.39M89.3%
COM SHS$45.64M4.8%
ORDINARY SHARES$27.58M2.9%
SPONSORED ADS$23.80M2.5%
COM SER A$4.53M0.5%
Portfolio Concentration
Top 3$317.37M33.4%
4–10$273.24M28.8%
11–25$300.73M31.7%
Rest$58.61M6.2%
Top 3 weight
33.4%
Top 10 weight
62.2%
Voting Authority Distribution
Total shares with voting rights: 117.25M
Sole
Full voting authority
117.25M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole37
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings37
Rows:
APOGEE THERAPEUTICS INC
SOLEShares8.49M
TypeSH
Market value$180.91M
19.04%
Sole
8.49M
Shared
0.00
None
0.00
RAYZEBIO INC
SOLEShares4.02M
TypeSH
Market value$89.17M
9.39%
Sole
4.02M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares3.08M
TypeSH
Market value$47.29M
4.98%
Sole
3.08M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares4.68M
TypeSH
Market value$45.67M
4.81%
Sole
4.68M
Shared
0.00
None
0.00
TAYSHA GENE THERAPIES INC
SOLEShares14.44M
TypeSH
Market value$45.64M
4.80%
Sole
14.44M
Shared
0.00
None
0.00
MERUS N V
SOLEShares1.73M
TypeSH
Market value$40.70M
4.28%
Sole
1.73M
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares2.95M
TypeSH
Market value$40.36M
4.25%
Sole
2.95M
Shared
0.00
None
0.00
4D MOLECULAR THERAPEUTICS IN
SOLEShares3M
TypeSH
Market value$38.19M
4.02%
Sole
3M
Shared
0.00
None
0.00
PHARVARIS N V
SOLEShares1.56M
TypeSH
Market value$32.63M
3.43%
Sole
1.56M
Shared
0.00
None
0.00
CABALETTA BIO INC
SOLEShares1.97M
TypeSH
Market value$30.03M
3.16%
Sole
1.97M
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares2.92M
TypeSH
Market value$28.09M
2.96%
Sole
2.92M
Shared
0.00
None
0.00
GH RESEARCH PLC
SOLEShares2.74M
TypeSH
Market value$27.58M
2.90%
Sole
2.74M
Shared
0.00
None
0.00
HILLEVAX INC
SOLEShares2.04M
TypeSH
Market value$27.40M
2.88%
Sole
2.04M
Shared
0.00
None
0.00
SAVARA INC
SOLEShares7.18M
TypeSH
Market value$27.16M
2.86%
Sole
7.18M
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
SOLEShares1.09M
TypeSH
Market value$24.99M
2.63%
Sole
1.09M
Shared
0.00
None
0.00
AMBRX BIOPHARMA INC
SOLEShares2.07M
TypeSH
Market value$23.80M
2.51%
Sole
2.07M
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares2.62M
TypeSH
Market value$23.46M
2.47%
Sole
2.62M
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares2.17M
TypeSH
Market value$19.48M
2.05%
Sole
2.17M
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares2.11M
TypeSH
Market value$19.24M
2.03%
Sole
2.11M
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares3.09M
TypeSH
Market value$15.55M
1.64%
Sole
3.09M
Shared
0.00
None
0.00
MERSANA THERAPEUTICS INC
SOLEShares11.33M
TypeSH
Market value$14.39M
1.51%
Sole
11.33M
Shared
0.00
None
0.00
APPLIED THERAPEUTICS INC
SOLEShares5.66M
TypeSH
Market value$14.09M
1.48%
Sole
5.66M
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares2.14M
TypeSH
Market value$12.96M
1.36%
Sole
2.14M
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares927.71K
TypeSH
Market value$12.68M
1.33%
Sole
927.71K
Shared
0.00
None
0.00
ADVERUM BIOTECHNOLOGIES INC
SOLEShares6.57M
TypeSH
Market value$9.86M
1.04%
Sole
6.57M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
APOGEE THERAPEUTICS INCSOLE | COM | 8.49M | SH | $180.91M 19.04% | 8.49M | 0.00 | 0.00 |
RAYZEBIO INCSOLE | COM | 4.02M | SH | $89.17M 9.39% | 4.02M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 3.08M | SH | $47.29M 4.98% | 3.08M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 4.68M | SH | $45.67M 4.81% | 4.68M | 0.00 | 0.00 |
TAYSHA GENE THERAPIES INCSOLE | COM SHS | 14.44M | SH | $45.64M 4.80% | 14.44M | 0.00 | 0.00 |
MERUS N VSOLE | COM | 1.73M | SH | $40.70M 4.28% | 1.73M | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 2.95M | SH | $40.36M 4.25% | 2.95M | 0.00 | 0.00 |
4D MOLECULAR THERAPEUTICS INSOLE | COM | 3M | SH | $38.19M 4.02% | 3M | 0.00 | 0.00 |
PHARVARIS N VSOLE | COM | 1.56M | SH | $32.63M 3.43% | 1.56M | 0.00 | 0.00 |
CABALETTA BIO INCSOLE | COM | 1.97M | SH | $30.03M 3.16% | 1.97M | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 2.92M | SH | $28.09M 2.96% | 2.92M | 0.00 | 0.00 |
GH RESEARCH PLCSOLE | ORDINARY SHARES | 2.74M | SH | $27.58M 2.90% | 2.74M | 0.00 | 0.00 |
HILLEVAX INCSOLE | COM | 2.04M | SH | $27.40M 2.88% | 2.04M | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 7.18M | SH | $27.16M 2.86% | 7.18M | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCSOLE | COM | 1.09M | SH | $24.99M 2.63% | 1.09M | 0.00 | 0.00 |
AMBRX BIOPHARMA INCSOLE | SPONSORED ADS | 2.07M | SH | $23.80M 2.51% | 2.07M | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | COM | 2.62M | SH | $23.46M 2.47% | 2.62M | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 2.17M | SH | $19.48M 2.05% | 2.17M | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 2.11M | SH | $19.24M 2.03% | 2.11M | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 3.09M | SH | $15.55M 1.64% | 3.09M | 0.00 | 0.00 |
MERSANA THERAPEUTICS INCSOLE | COM | 11.33M | SH | $14.39M 1.51% | 11.33M | 0.00 | 0.00 |
APPLIED THERAPEUTICS INCSOLE | COM | 5.66M | SH | $14.09M 1.48% | 5.66M | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 2.14M | SH | $12.96M 1.36% | 2.14M | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 927.71K | SH | $12.68M 1.33% | 927.71K | 0.00 | 0.00 |
ADVERUM BIOTECHNOLOGIES INCSOLE | COM | 6.57M | SH | $9.86M 1.04% | 6.57M | 0.00 | 0.00 |
Page 1 of 2